Diagnostic assays and test kits comprised of primers, probes, buffers, and reagents for use in laboratory and chemical research and development and used to predict diseases

Diagnostic assays and test kits comprised of primers, probes, buffers, and reagents for clinical use to diagnose, prognose or treat diseases

Medical diagnostic services, namely, diagnosing, preventing and predicting disease, identifying risk factors of disease, prognostic testing, gene and protein testing, identifying physiological characteristics, and evaluating efficacy of treatment; medical diagnostic services, namely, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and activity, evaluating clinical trial progress, and drug monitoring and monitoring of patient health progression; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors; computer services, namely, computer tracking of and providing access to databases of life sciences information via global, national and local computer networks in the field of pharmacogenomics, diagnostics, personalized medicine and toxicogenomics